Search results
Found 7347 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Biomedical Training Courses
Our courses are aimed at people who are applying to the Home Office for Personal or Project Licences.
Find Out More
Updates about the ESM pilot